Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Kriajevska, M. Cardenas, Mariam Grigorian, N. Ambartsumian, G Georgiev, Lukanidin Em (1994)
Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene.The Journal of biological chemistry, 269 31
(1995)
Overexpression of MDM2 mRNA and Mutation of the p 53 Tumor Suppressor Gene in Bladder Carcinoma Cell Lines
M. Kriajevska, S. Tarabykina, I. Bronstein, N. Maitland, M. Lomonosov, K. Hansen, G. Georgiev, E. Lukanidin (1998)
Metastasis-associated Mts1 (S100A4) Protein Modulates Protein Kinase C Phosphorylation of the Heavy Chain of Nonmuscle Myosin*The Journal of Biological Chemistry, 273
K. Takenaga, Y. Nakamura, S. Sakiyama, Y. Hasegawa, K. Sato, H. Endo (1994)
Binding of pEL98 protein, an S100-related calcium-binding protein, to nonmuscle tropomyosinThe Journal of Cell Biology, 124
N. Wang, H. To, W. Lee, E. Lee (1993)
Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.Oncogene, 8 2
(1991)
Wild - Type p 53 Suppresses Growth of Human
D. Katayose, J. Gudas, H. Nguyen, S. Srivastava, K. Cowan, P. Seth (1995)
Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells.Clinical cancer research : an official journal of the American Association for Cancer Research, 1 8
S. Sengupta, J. Vonesch, C. Waltzinger, Hong Zheng, B. Wasylyk (2000)
Negative cross‐talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cellsThe EMBO Journal, 19
P. Jara, S. Gilbert, P. Delmas, J. Guillemot, M. Kaghad, P. Ferrara, G. Loison (1996)
Cloning and characterization of theMolecular Genetics and Genomics, 250
E. Elstner, M. Linker-Israeli, T. Umiel, S. Vos, I. Shintaku, D. Heber, L. Binderup, M. Uskoković, H. Koeffler (1995)
and Inducers of Differentiation of Human Breast Cancer Cell Lines
L. Jayaraman, C. Prives (1999)
Covalent and noncovalent modifiers of the p53 proteinCellular and Molecular Life Sciences CMLS, 55
J. Nigro, S. Baker, A. Preisinger, J. Jessup, Richard Hosteller, Karen Cleary, Sandra Signer, N. Davidson, S. Baylin, P. Devilee, T. Glover, F. Collins, Ainsley Weslon, R. Modali, C. Harris, B. Vogelstein (1989)
Mutations in the p53 gene occur in diverse human tumour typesNature, 342
D. Zimmer, E. Cornwall, A. Landar, Wei-Zheng Song (1995)
The S100 protein family: History, function, and expressionBrain Research Bulletin, 37
Nanda Rodrigues, A. Rowan, Mark Smith, I. Kerr, W. Bodmer, J. Gannon, D. Lane (1990)
p53 mutations in colorectal cancer.Proceedings of the National Academy of Sciences of the United States of America, 87
Masaki Kimura, Masatoshi Tagawa, K. Takenaga, Taketo Yamaguchi, H. Saisho, Akira Nakagawara, Shigeru Sakiyama (1997)
Inability to induce the alteration of tumorigenicity and chemosensitivity of p53-null human pancreatic carcinoma cells after the transduction of wild-type p53 gene.Anticancer research, 17 2A
Romano Jw, Ehrhart Jc, Arlette Duthu, Kim Cm, Ettore Appella, Pierre May (1989)
Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.Oncogene, 4 12
M. Mundt, T. Hupp, M. Fritsche, C. Merkle, S. Hansen, D. Lane, B. Groner (1997)
Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potentialOncogene, 15
M. Oren, C. Prives (1996)
p53: upstream, downstream and off stream. Review of the 8th p53 workshop (Dundee, July 5-9, 1996).Biochimica et biophysica acta, 1288 3
H. Wang, R Mohammad, J. Werdell, P. Shekhar (1998)
p53 and protein kinase C independent induction of growth arrest and apoptosis by bryostatin 1 in a highly metastatic mammary epithelial cell line: In vitro versus in vivo activity.International journal of molecular medicine, 1 6
E. Lukanidin, G.P. Georgiev (1996)
Current Topics in Microbiology and Immunology: Attempts to Understand Metastasis Formation
A. Gartel, M. Serfas, Medeia Gartel, Eugene Goufman, Gen Wu, W. El-Deiry, A. Tyner (1996)
p21 (WAF1/CIP1) expression is induced in newly nondividing cells in diverse epithelia and during differentiation of the Caco-2 intestinal cell line.Experimental cell research, 227 2
E. Elstner, Mariana Linker-Israeli, Jonathan Said, T. Umiel, S. Vos, I. Shintaku, David Heber, Lise Binderup, M. Uskoković, H. Koeffler (1995)
20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.Cancer research, 55 13
(1994)
phologic Transformation of the C 3 H 10 T 1 / 2 Cell Line Is Accompanied by Altered Expression of the p 53 Tumor Suppressor Gene
Á. Lányi, D. Deb, R. Seymour, J. Ludes-Meyers, M. Subler, S. Deb (1998)
`Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domainOncogene, 16
Xiaolong Yang, A. Pater, Shou-Ching Tang (1999)
Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutantsOncogene, 18
J. Kovach, R. McGovern, J. Cassady, Selene Swanson, L. Wold, B. Vogelstein, S. Sommer (1991)
Direct sequencing from touch preparations of human carcinomas: analysis of p53 mutations in breast carcinomas.Journal of the National Cancer Institute, 83 14
Ya‐Tse Cheng, Yu-ling Li, Jeng-Dau Wu, Shi Long, T. Tzai, C. Tzeng, M. Lai (1995)
Overexpression of MDM‐2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell linesMolecular Carcinogenesis, 13
D. Olson, A. Levine (1994)
The properties of p53 proteins selected for the loss of suppression of transformation.Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 5 1
(1989)
Identification and Characterization of a p53 Gene Mutation in a RUSSIAN JOURNAL OF GENETICS Vol. 39 No. 7 2003 METASTASIS-INDUCING Mts1/S100A4 PROTEIN 755 Human Osteosarcoma
David Roberts (1996)
Regulation of tumor growth and metastasis by thrombospondin‐1The FASEB Journal, 10
A. Platt-Higgins, C. Renshaw, C. West, J. Winstanley, S. Rudland, R. Barraclough, P. Rudland (2000)
Comparison of the metastasis‐inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancerInternational Journal of Cancer, 89
C. Felix, Cynthia Kappel, T. Mitsudomi, M. Nau, M. Tsokos, G. Crouch, P. Nisen, N. Winick, L. Helman (1992)
Frequency and Diversity of P53 Mutations in Childhood Updated Version Citing Articles E-mail Alerts Frequency and Diversity of P53 Mutations in Childhood Rhabdomyosarcoma
G. Casey, M. Lo-Hsueh, M. Lopez, B. Vogelstein, E. Stanbridge (1991)
Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.Oncogene, 6 10
W. Isaacs, B. Carter, C. Ewing (1991)
Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.Cancer research, 51 17
S. Hayashi, E. Kano, H. Matsumoto, M. Hatashita, T. Ohtsubo, T. Nishida, H. Shioura, R. Kitai (1999)
Thermosensitivity, incidence of apoptosis and accumulations of hsp72 and p53 proteins of murine L cells in wild type status of p53 gene.Journal of experimental & clinical cancer research : CR, 18 2
T. Hupp (1999)
Regulation of p53 protein function through alterations in protein-folding pathwaysCellular and Molecular Life Sciences CMLS, 55
R. Wadhwa, S. Takano, Martin Robert, A. Yoshida, H. Nomura, R. Reddel, Y. Mitsui, S. Kaul (1998)
Inactivation of Tumor Suppressor p53 by Mot-2, a hsp70 Family Member*The Journal of Biological Chemistry, 273
A. Levine (1997)
p53, the Cellular Gatekeeper for Growth and DivisionCell, 88
D. Dittmer, Sibani Pati, G. Zambetti, Shelley Chu, A. Teresky, M. Moore, C. Finlay, A. Levine (1993)
Gain of function mutations in p53Nature Genetics, 4
T. Hupp, D. Meek, C. Midgley, D. Lane (1992)
Regulation of the specific DNA binding function of p53Cell, 71
M. Frazier, Xiaoping He, Jinling Wang, Z. Gu, J. Cleveland, G. Zambetti (1998)
Activation of c-myc Gene Expression by Tumor-Derived p53 Mutants Requires a Discrete C-Terminal DomainMolecular and Cellular Biology, 18
M. Oren, C. Prives (1996)
p53: Upstream, Downstream and Off StreamBiochim. Biophys. Acta, 9
O. Kustikova, D. Kramerov, M. Grigorian, V. Berezin, E. Bock, E. Lukanidin, E. Tulchinsky (1998)
Fra-1 Induces Morphological Transformation and Increases In Vitro Invasiveness and Motility of Epithelioid Adenocarcinoma CellsMolecular and Cellular Biology, 18
Richard Rust, D. Baldisseri, David Weber (2000)
Structure of the negative regulatory domain of p53 bound to S100B(ββ)Nature Structural Biology, 7
K. O'connell, M. Edidin (1990)
A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells.Journal of immunology, 144 2
A. Ebralidze, Eugene insky, M. Grigorian, Anna Afanasyeva, Viaches Senin, E. Revazova, E. Lukanidin (1989)
Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family.Genes & development, 3 7
(1999)
Cytotoxic Effects of AdenovirusMediated Wild - Type p 53 Protein Expression in Normal and Tumor Mammary Epithelial Cells
Yasuo Watanabe, Nobuteru Usada, H. Minami, T. Morita, S. Tsugane, R. Ishikawa, K. Kohama, Y. Tomida, Hiroyoshi Hidaka (1993)
Calvasculin, as a factor affecting the microfilament assemblies in rat fibroblasts transfected by src geneFEBS Letters, 324
L. Ko, C. Prives (1996)
p53: puzzle and paradigm.Genes & development, 10 9
P. Rudland, A. Platt-Higgins, C. Renshaw, C. West, J. Winstanley, L. Robertson, R. Barraclough (2000)
Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.Cancer research, 60 6
E. Lukanidin, G. Georgiev (1996)
Metastasis-related mts1 gene.Current topics in microbiology and immunology, 213 ( Pt 2)
G. Selivanova, V. Iotsova, İ. Okan, M. Fritsche, M. Ström, B. Groner, R. Grafström, K. Wiman (1997)
Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domainNature Medicine, 3
(1995)
Muta - tions in the p 53 Gene Occur in Diverse Human Tumor Types
Y. Yaginuma, H. Westphal (1991)
Analysis of the p53 gene in human uterine carcinoma cell lines.Cancer research, 51 24
W. Coleman, J. Grisham, G. Smith (1994)
Morphologic transformation of the C3H 10T1/2 cell line is accompanied by altered expression of the p53 tumor suppressor gene.Carcinogenesis, 15 2
(2000)
Comparison of the MetastasisInducing Protein S 100 A 4 ( p 9 ka ) with Other Prognostic Markers in Human Breast Cancer
N. Ambartsumian, J. Klingelhöfer, M. Grigorian, C. Christensen, M. Kriajevska, E. Tulchinsky, G. Georgiev, V. Berezin, E. Bock, J. Rygaard, R. Cao, Yihai Cao, E. Lukanidin (2001)
The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factorOncogene, 20
(1991)
Analysis of the p 53 Gene in Human Uterine Carcinoma Cell Lines
This study for the first time demonstrates a physical and functional interaction between the Ca2+-binding protein Mts1/S100A4 and tumor suppressor p53 protein. Using different in vitro and in vivo approaches, we have found that Mts1 can bind to the C-terminal regulatory domain of p53. The Mts1 binding to p53 promotes activation of the reporter gene transcription in vivo. A modulation of the p53 target gene (p21/WAF,bax, mdm-2, and thrombospondin-1) expression was observed upon Mts1 induction in the cells expressing the wild-type p53. These results suggest that the ability of Mts1 to enhance p53-dependent apoptosis of tumor cells leads to the decrease/disappearance of the tumor cells expressing the wild-type p53. Thus, Mts1 promotes selection of more aggressive, metastatic phenotype during tumor progression.
Russian Journal of Genetics – Springer Journals
Published: Oct 7, 2004
Access the full text.
Sign up today, get DeepDyve free for 14 days.